Drugs / TDF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00984152 Comparator | Jun 2011 → Jun 2013 | HIV infectious disease | Rush University Medical Center | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TDF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00984152 ↗ |
| Route | Oral | “TDF/FTC (Truvada, 300/200 mg) One PO Daily” NCT00984152 ↗ |